greeksoup/ stock research

U S Physical Therapy (USPH) FY2024 results: revenue $671 million, up 11.0% on the year

U S Physical Therapy Inc. (USPH) reported revenue of $671 million for fiscal 2024, the year ended 31 December 2024, up 11.0% on the year before. Net income was $31 million, up 11.3%, and diluted earnings per share $1.84. The figures are the company's own, from the 10-K it filed with the SEC on 3 March 2025.

Revenue
$671 million
+11.0% on the year
FY2017FY2024
Operating margin
9.4%
8.4% a year earlier
FY2017FY2024
Net income
$31 million
+11.3% on the year
FY2017FY2024
Diluted EPS
$1.84
+43.8% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue671605553+11.0%
Gross profit124122112+2.0%
Gross margin18.5%20.1%20.3%
Selling, general and administrative58.352.046.1+12.2%
Operating income63.050.556.8+24.7%
Operating margin9.4%8.4%10.3%
Pre-tax income60.249.455.6+21.9%
Income tax14.612.212.2+20.2%
Effective tax rate24.3%24.6%21.9%
Net income31.428.232.2+11.3%
Net margin4.7%4.7%5.8%
Diluted EPS$1.84$1.28$2.25+43.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow74.982.058.5-8.6%
Capital expenditure9.29.38.2-1.2%
Free cash flow65.872.750.3-9.5%
Free cash flow margin9.8%12.0%9.1%
Cash from investing-149-45.0-81.3
Cash from financing-37.084.325.8
Depreciation and amortisation18.715.714.7+19.0%
Share-based compensation7.87.27.3+8.1%
Buybacks0.00.0n/a
Dividends paid26.524.121.3+10.0%
Dividend per share$1.76$1.72$1.64+2.3%
Diluted shares, weighted15m14m13m+6.2%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity489476316+2.7%
Non-controlling interest1.11.21.3-10.2%
Redeemable equity269175168+53.9%
Debt154147184+4.7%
Operating lease liabilities10276.777.9+32.9%
Other liabilities153122112+25.8%
Total liabilities and equity1,167997858+17.1%
Fixed assets32.126.124.7+23.1%
Goodwill667510494+30.9%
Intangible assets179110109+63.5%
Cash and equivalents41.415331.6-72.9%
Receivables59.051.951.9+13.8%
Other assets188147147+28.0%
Total assets1,167997858+17.1%

10-K for the year ended 31 December 2024, filed 3 March 2025: the filing.